Mortality patterns among critically ill children in a Pediatric Intensive Care Unit of a developing country

Naveed-Ur-Rehman Siddiqui1, Zohaib Ashraf2, Humaira Jurair1

  • 1Department of Pediatric and Child Health, Aga Khan University Medical College, Karachi, Pakistan.

Insights

Limitation of life-sustaining treatment was the leading cause of death in a Pakistan Pediatric Intensive Care Unit (PICU). Parents were consistently involved in end-of-life decisions for critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Bioethics
  • Health Outcomes Research

Background:

  • Biomedical advances prolong life but can increase patient suffering.
  • Limitation of life-sustaining treatment is a critical ethical consideration.
  • Understanding mortality patterns in developing countries is essential.

Purpose of the Study:

  • To analyze mortality patterns in a Pakistani Pediatric Intensive Care Unit (PICU) over six years.
  • To identify the primary causes of death in critically ill children.
  • To compare findings with international data on end-of-life care.

Main Methods:

  • Retrospective cohort study design.
  • Analysis of medical records from a tertiary care hospital PICU in Pakistan.
  • Inclusion of children aged 1 month to 16 years who died between 2007 and 2012.

Main Results:

  • Overall mortality rate was 12.9% (248 deaths out of 1919 admissions).
  • Limitation of life-sustaining treatment (63.7%) was the most frequent cause of death, followed by failed cardiopulmonary resuscitation (28.2%).
  • An increasing trend in do-not-resuscitate (DNR) orders was observed over the study period.

Conclusions:

  • Limitation of life support treatment, encompassing DNR and withdrawal of care, is the predominant cause of death in this PICU.
  • Parental involvement in end-of-life decision-making was a consistent aspect of care.
  • Findings highlight the importance of ethical considerations in pediatric critical care in developing nations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
851
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
896